Carlos Perez

Carlos Perez

Auto-generated profile, based on publicly available information

Carlos Perez

Lilly Research Laboratories, Alcobendas, Spain

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2024 in Nature
Verified
Journal Article
Open access
PDF file
NDNuria Diaz
Nuria Diaz
CPCarlos Alberto Pérez
Carlos Alberto Pérez
AEAna Maria Escribano
Ana Maria Escribano
GSGema Sanz
Gema Sanz
JPJulian Priego
Julian Priego
LMLaura F. Michael
Laura F. Michael
Lipoprotein(a) (Lp(a)), an independent, causal cardiovascular risk factor, is a lipoprotein particle that is formed by the interaction of a low-density lipoprotein (LDL) particle and apolipoprotein(a) (apo(a))1,2. Apo(a) first binds to lysine residues of apolipoprotein B-100 (apoB-100) on LDL through the Kringle IV (KIV) 7 and 8 domains, before a disulfide bond forms between apo(a) and apoB-100 to create Lp(a) (refs. 3–7). Here we show that the first step of Lp(a) formation can be inhibited through small-molecule interactions with apo(a) KIV7–8. We identify compounds that bind to apo(a) KIV7–8, and, through chemical optimization and further application of multivalency, we create compounds with subnanomolar potency that inhibit the formation of Lp(a). Oral doses of prototype compounds and a potent, multivalent disruptor, LY3473329 (muvalaplin), reduced the levels of Lp(a) in transgenic mice and in cynomolgus monkeys. Although multivalent molecules bind to the Kringle domains of rat plasminogen and reduce plasmin activity, species-selective differences in plasminogen sequences suggest that inhibitor molecules will reduce the levels of Lp(a), but not those of plasminogen, in humans. These data support the clinical development of LY3473329—which is already in phase 2 studies—as a potent and specific orally administered agent for reducing the levels of Lp(a).

1 December 2001 in Combinatorial Chemistry & High Throughput Screening
Verified
Journal Article
Closed access
PDF file
CCCarmen Cuevas
Carmen Cuevas
Manuel PastorManuel Pastor
Manuel Pastor
CPCarlos Alberto Pérez
Carlos Alberto Pérez
FGFederico Gago
Federico Gago
The complexes of human neutrophil elastase with a series of 40 N3-substituted trifluoromethylketone-based pyridone inhibitors have been modelled. The series spans three orders of magnitude in inhibition constants despite the fact that it was originally developed in an attempt to improve the oral activity of a lead compound. Ligand-receptor interaction energies calculated using molecular mechanics did not correlate well with the experimental activities. A good correlation with activity was found, however, when a COMBINE analysis of the same data was carried out, which allowed a quantitative interpretation of the modelled complexes. The essence of this method is to partition the ligand-receptor interaction energies into individual residue-based van der Waals and electrostatic contributions, and to subject the resulting energy matrix to partial least squares analysis. Incorporation of two additional descriptors representing the electrostatic energy contributions to the partial desolvation of both the re ceptor and the ligands improved the QSAR model, as did the replacement of the distance-dependent electrostatic contributions with solvent-screened electrostatic interactions calculated by numerically solving the Poisson-Boltzmann equation. The model was validated both internally (cross-validation) and externally, using a set of twelve 6-phenyl-pyridopyrimidine analogs. The analysis reveals the subtle interplay of binding forces which occurs within the enzyme active site and provides objective information that can be interpreted in the light of the receptor structure. This information, gained from a series of real compounds, can be easily translated into 3D real or virtual database queries in the search for more active derivatives.

1 April 2011 in Chemical Physics Letters
Verified
Journal Article
Closed access
SSSônia M.L. Silva
Sônia M.L. Silva
LCLetícia N. Coelho
Letícia N. Coelho
ÂSÂngelo Malachias de Souza
Ângelo Malachias de Souza
CPCarlos Alberto Pérez
Carlos Alberto Pérez
JPJorge L. Pesquero
Jorge L. Pesquero
MOMônica Cristina Oliveira
Mônica Cristina Oliveira